Nang Kuang Pharm Co Company Profile
What is the competitive landscape for NANG KUANG PHARM CO
NANG KUANG PHARM CO has five approved drugs.
Drugs and US Patents for Nang Kuang Pharm Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nang Kuang Pharm Co | IBANDRONATE SODIUM | ibandronate sodium | INJECTABLE;INTRAVENOUS | 204329-001 | Jun 16, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nang Kuang Pharm Co | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;INTRAVENOUS | 206554-002 | Jun 7, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nang Kuang Pharm Co | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;INTRAVENOUS | 206554-001 | Jun 7, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nang Kuang Pharm Co | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 207354-002 | Dec 20, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

